Vera Therapeutics Inc.

NASDAQ: VERA · Real-Time Price · USD
21.55
0.28 (1.32%)
At close: Aug 15, 2025, 3:59 PM
21.21
-1.58%
After-hours: Aug 15, 2025, 07:17 PM EDT

Vera Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 1.86M n/a n/a
Cost of Revenue
n/a n/a -846K 176K
Gross Profit
n/a 1.86M 846K -176K
Operating Income
-167.17M -102.01M -90.9M -34.4M
Interest Income
20.71M 4.19M 1.75M 15K
Pretax Income
-152.15M -95.99M -89.06M -32.61M
Net Income
-152.15M -95.99M -89.06M -32.61M
Selling & General & Admin
41M 23.79M 21.91M 11.92M
Research & Development
126.17M 78.22M 68.99M 22.48M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
167.17M 102.01M 90.9M 34.4M
Interest Expense
7.63M n/a 992K 20K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 102.01M 90.9M 34.4M
Income Tax Expense
1K 1K 1K 1K
Shares Outstanding (Basic)
55.33M 42.71M 26.57M 21.28M
Shares Outstanding (Diluted)
55.33M 42.71M 26.57M 21.28M
EPS (Basic)
-2.75 -2.25 -3.35 -1.53
EPS (Diluted)
-2.75 -2.25 -3.35 -1.53
EBITDA
-167.17M -102.01M -90.9M -34.23M
EBIT
-159.77M -102.01M -88.06M -34.4M
Depreciation & Amortization
-7.4M n/a -846K 176K